Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Indonesia Invstble Mkt Idx MSCI Ishares | EIDO | Nov 22, 2024 | 19.98 | +0.60 |
Indust/Producer Dur Alphadex First Trust | FXR | Nov 22, 2024 | 82.15 | +1.08 |
Industrial Logistics Properties Trust | ILPT | Nov 22, 2024 | 3.70 | +1.09 |
Industrial Select Sector SPDR | XLI | Nov 22, 2024 | 142.65 | +1.39 |
Industrials ETF Vanguard | VIS | Nov 22, 2024 | 276.74 | +1.25 |
Infinera | INFN | Nov 22, 2024 | 6.64 | +0.45 |
InflaRx N.V | IFRX | Nov 22, 2024 | 2.08 | +0.97 |
Inflection Point Acquisition II | IPXX | Nov 22, 2024 | 10.70 | -0.14 |
Inflection Point Acquisition II Unit | IPXXU | Nov 22, 2024 | 10.86 | 0.00 |
Infobird | IFBD | Nov 22, 2024 | 1.84 | +3.95 |
Informatica | INFA | Nov 22, 2024 | 26.36 | -0.34 |
Information Services Group | III | Nov 22, 2024 | 3.53 | +5.85 |
Information Technology ETF Vanguard | VGT | Nov 22, 2024 | 621.58 | +0.37 |
Infosys ADR | INFY | Nov 22, 2024 | 22.79 | +3.78 |
InfuSystems | INFU | Nov 22, 2024 | 9.33 | +0.97 |
ING Group ADR | ING | Nov 22, 2024 | 15.28 | -2.30 |
Ingersoll Rand | IR | Nov 22, 2024 | 104.00 | +0.93 |
Ingevity | NGVT | Nov 22, 2024 | 48.56 | +0.31 |
Ingles Markets A | IMKTA | Nov 22, 2024 | 72.18 | +2.63 |
Ingram Micro Holding Corp | INGM | Nov 22, 2024 | 22.00 | 0.00 |
Ingredion | INGR | Nov 22, 2024 | 146.47 | +1.46 |
Inhibikase Therapeutics | IKT | Nov 22, 2024 | 2.31 | +14.93 |
Inhibrx Biosciences | INBX | Nov 22, 2024 | 14.08 | +0.72 |
InMed Pharmaceuticals | INM | Nov 22, 2024 | 4.66 | +0.22 |
InMode | INMD | Nov 22, 2024 | 19.02 | +2.89 |
INmune Bio | INMB | Nov 22, 2024 | 4.87 | +2.31 |
Innate Pharma ADR | IPHA | Nov 22, 2024 | 1.63 | -4.12 |
Inno Holdings | INHD | Nov 22, 2024 | 4.96 | -1.98 |
Innodata | INOD | Nov 22, 2024 | 44.77 | -3.16 |
Innospec | IOSP | Nov 22, 2024 | 119.75 | +1.19 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.